Security & deployment

Keep clinical data inside the clinical environment.

LYNNAGEN is designed around separation between the public website and the clinical application. Security controls, regulatory validation, and institutional governance remain deployment responsibilities of the implementing organization.

Current positioning: this page describes product architecture and design principles. It does not claim HIPAA, SOC 2, ISO 27001, FDA, CE, or other certifications that have not been formally obtained.

Public website separation

The marketing website should contain public product information only. Patient identifiers, genomic files, case records, and clinical evidence databases should not pass through website analytics, forms, or hosting infrastructure.

Controlled clinical deployment

The clinical application is intended to operate inside a controlled environment with institution-appropriate access control, endpoint protection, backups, network policy, and audit procedures.

Data locality

Large evidence datasets, case storage, reference genomes, calling runtimes, and local annotation resources can remain within the clinical deployment rather than being bundled into the public website.

Evidence integrity

Variant identity, assembly, reference validation, evidence provenance, technical QC, and patient relevance are kept explicit so reviewers can inspect the basis and limitations of an interpretation.

Professional review

LYNNAGEN is decision-support software. Final clinical or laboratory interpretation remains with the qualified reviewer.